February 26, 2020 / 11:09 PM / a month ago

BRIEF-Acadia Pharmaceuticals Reports Q4 Loss Per Share $0.34

Feb 26 (Reuters) - ACADIA Pharmaceuticals Inc:

* ACADIA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* SEES FY 2020 SALES $440 MILLION TO $470 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $-0.36 — REFINITIV IBES DATA

* Q4 REVENUE VIEW $96.8 MILLION — REFINITIV IBES DATA

* SEES 2020 GAAP RESEARCH AND DEVELOPMENT TO BE BETWEEN $270 MILLION AND $285 MILLION

* SEES 2020 GAAP SG&A IS EXPECTED TO BE BETWEEN $440 MILLION AND $460 MILLION

* SEES 2020 YEAR-END CASH, CASH EQUIVALENTS, AND INVESTMENT SECURITIES TO BE BETWEEN $470 MILLION AND $500 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below